Commission Regulation (EC) No 712/2005 of 11 May 2005 amending Annexes I and II to Council Regulation (EEC) No 2377/90 laying down a Community procedure for the establishment of maximum residue limits of veterinary medicinal products in foodstuffs of animal origin as regards lasalocid and ammonium and sodium salts of bituminosulfonates  (Text with EEA relevance)
Date: 2005-05-11
Institutions: European Commission
Subjects: animal product, foodstuff, health policy, material of animal origin, veterinary drug

12.5.2005

EN

Official Journal of the European Union

L 120/3

COMMISSION REGULATION (EC) No 712/2005

of 11 May 2005

amending Annexes I and II to Council Regulation (EEC) No 2377/90 laying down a Community
procedure for the establishment of maximum residue limits of veterinary medicinal products
lasalocid and ammonium and sodium salts of
in foodstuffs of animal origin as

regards
bituminosulfonates

(Text with EEA relevance)

THE COMMISSION OF THE EUROPEAN COMMUNITIES,

(5)

Having regard to the Treaty
Community,

establishing the European

Having regard to Council Regulation (EEC) No 2377/90 of 26
June 1990 laying down a Community procedure for the estab-
lishment of maximum residue limits of veterinary medicinal
products in foodstuffs of animal origin (1), and in particular
Articles 2 and 3 and the third subparagraph of Article 4 thereof,

Having regard to the opinions of
the European Medicines
Agency formulated by the Committee for Medicinal Products
for Veterinary Use,

Whereas:

(6)

An adequate period should be allowed before the appli-
cability of this Regulation in order to enable Member
States to make any adjustment which may be necessary
in the light of this Regulation to the authorisations to
place the veterinary medicinal products concerned on the
market which have been granted in accordance with
Directive 2001/82/EC of the European Parliament and
of
the Council of 6 November 2001 on the
to veterinary medicinal
Community
products (2) to take account of the provisions of this
Regulation.

relating

code

The measures provided for in this Regulation are in
accordance with
Standing
the
the
Committee on Veterinary Medicinal Products,

opinion

of

(1)

(2)

(3)

All pharmacologically active substances which are used
within the Community in veterinary medicinal products
intended for administration to food-producing animals
should be evaluated in accordance with Regulation
(EEC) No 2377/90.

The substance lasalocid should be included in Annex I
for poultry excluding animals from which eggs are
produced for human consumption.

The substances ammonium and sodium salts of bitumi-
nosulfonates have been included in Annex II
for all
mammalian food producing species excluding animals
from which milk is produced for human consumption.
The entry for those substances should be extended to
cover dairy cattle.

HAS ADOPTED THE FOLLOWING REGULATION:

Article 1

Annexes I and II to Regulation (EEC) No 2377/90 are amended
in accordance with the Annex to this Regulation.

Article 2

This Regulation shall enter into force on the third day following
its publication in the Official Journal of the European Union.

(4)

Regulation (EEC) No 2377/90 should be amended
accordingly.

It shall apply from 11 July 2005.

This Regulation shall be binding in its entirety and directly applicable in all Member States.

Done at Brussels, 11 May 2005.

For the Commission

Günter VERHEUGEN
Vice-President

(1) OJ L 224, 18.8.1990, p. 1. Regulation as

last amended by
Commission Regulation (EC) No 75/2005 (OJ L 15, 19.1.2005,
p. 3).

(2) OJ L 311, 28.11.2001, p. 1. Directive as last amended by Directive

2004/28/EC (OJ L 136, 30.4.2004, p. 58).

L 120/4

EN

Official Journal of the European Union

12.5.2005

s
e
u
s
s
i
t

t
e
g
r
a
T

s
L
R
M

s
e
i
c
e
p
s

l
a
m
n
A

i

e
u
d
i
s
e
r

r
e
k
r
a
M

)
s
(
e
c
n
a
t
s
b
u
s

e
v
i
t
c
a

l

y
l
l
a
c
i
g
o
o
c
a
m
r
a
h
P

s
e
r
o
h
p
o
n
o
I

.

t
a
f
+
n
k
S

i

e
l
c
s
u
M

y
e
n
d
K

i

r
e
v
i
L

g
k
/
g

μ
0
2

g
k
/
g

μ
0
0
1

g
k
/
g

μ
0
0
1

g
k
/
g

μ
0
5

)
1
(

y
r
t
l
u
o
P

A

d
i
c
o
l
a
s
a
L

d
i
c
o
l
a
s
a
L

‘

’

.

n
o
i
t
p
m
u
s
n
o
c

n
a
m
u
h

r
o
f

d
e
c
u
d
o
r
p

e
r
a

s
g
g
e

h
c
i
h
w

m
o
r
f

s
l
a
m
n
a

i

n

i

e
s
u

r
o
f

t
o
N

)
1
(

.

4
4
2

.

X
E
N
N
A

0
9
/
7
7
3
2

o
N

)

C
E
E
(

n
o
i
t
a
l
u
g
e
R

o
t

I

x
e
n
n
A

n

i

d
e
t
r
e
s
n

i

)
e
r
a
(
s
i

)
s
(
e
c
n
a
t
s
b
u
s

i

g
n
w
o

l
l

o
f

e
h
T

.

A

a
o
z
o
t
o
r
p

t
s
n
i
a
g
a

g
n
i
t
c
a

s
t
n
e
g
A

.

4
2

.

s
t
n
e
g
a

c
i
t
i
s
a
r
a
p
i
t
n
A

.

2

s
e
i
c
e
p
s

l
a
m
n
A

i

)
s
(
e
c
n
a
t
s
b
u
s

e
v
i
t
c
a

l

y
l
l
a
c
i
g
o
o
c
a
m
r
a
h
P

)
1
(

s
e
i
c
e
p
s

g
n
i
c
u
d
o
r
p

d
o
o
f

n
a
i
l
a
m
m
a
m

l
l

A

s
t
l
a
s

i

m
u
d
o
s

d
n
a

i

m
u
n
o
m
m
a

,
s
e
t
a
n
o
f
l
u
s
o
n
m
u
t
i
B

i

‘

’

.

y
l
n
o

e
s
u

l
a
c
i
p
o
t

r
o
F

)
1
(

s
d
n
u
o
p
m
o
c

c
i
n
a
g
r
O

.

2

0
9
/
7
7
3
2

o
N

)

C
E
E
(

n
o
i
t
a
l
u
g
e
R

o
t

I
I

x
e
n
n
A

n

i

d
e
t
r
e
s
n

i

)
e
r
a
(
s
i

)
s
(
e
c
n
a
t
s
b
u
s

i

g
n
w
o

l
l

o
f

e
h
T

.

B